Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

Is Curcumin a Safe and Effective Therapeutic in the Treatment against Oral Lichen Planus?

Author(s): Motahareh Khosrojerdi, Eric Gumpricht, Tannaz Jamialahmadi, Prashant Kesharwani and Amirhossein Sahebkar*

Volume 30, Issue 15, 2023

Published on: 23 December, 2022

Page: [1684 - 1688] Pages: 5

DOI: 10.2174/0929867330666221202150727

Price: $65

Abstract

Oral lichen planus (OLP) is a chronic mucocutaneous, immunological disease that occurs more frequently in the buccal mucosa of middle-aged female patients. OLP's standard treatment is topical or systemic corticosteroids. Due to corticosteroids’ numerous potential side effects, there is an effort to find an alternative treatment. One alternative treatment is curcumin. Several studies have investigated the effectiveness and safety of curcumin in OLP patients. In this review, we summarized the literature focusing on the effectiveness and safety of curcumin in OLP patients. Our review of clinical trials revealed that either 6000 mg/day curcumin, 80 mg/day nano-curcumin, or 1% curcumin oral gel 6 times/day offered benefits in the treatment of OLP.

« Previous Next »
[1]
Lavanya, N.; Rao, U.K.; Jayanthi, P.; Ranganathan, K. Oral lichen planus: An update on pathogenesis and treatment. J. Oral Maxillofac. Pathol., 2011, 15(2), 127-132.
[http://dx.doi.org/10.4103/0973-029X.84474] [PMID: 22529568]
[2]
Le Cleach, L.; Chosidow, O. Lichen planus. N. Engl. J. Med., 2012, 366(8), 723-732.
[http://dx.doi.org/10.1056/NEJMcp1103641] [PMID: 22356325]
[3]
Thongprasom, K.; Dhanuthai, K. Steriods in the treatment of lichen planus: A review. J. Oral Sci., 2008, 50(4), 377-385.
[http://dx.doi.org/10.2334/josnusd.50.377] [PMID: 19106464]
[4]
Yixuan, L.; Qaria, M.A.; Sivasamy, S.; Jianzhong, S.; Daochen, Z. Curcumin production and bioavailability: A comprehensive review of curcumin extraction, synthesis, biotransformation and delivery systems. Ind. Crops Prod., 2021, 172, 114050.
[http://dx.doi.org/10.1016/j.indcrop.2021.114050]
[5]
Alidadi, M.; Jamialahmadi, T.; Cicero, A.F.G.; Bianconi, V.; Pirro, M.; Banach, M.; Sahebkar, A. The potential role of plant-derived natural products in improving arterial stiffness: A review of dietary intervention studies. Trends Food Sci. Technol., 2020, 99, 426-440.
[http://dx.doi.org/10.1016/j.tifs.2020.03.026]
[6]
Panahi, Y.; Ghanei, M.; Bashiri, S.; Hajihashemi, A.; Sahebkar, A. Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: Positive results of a randomized double-blind placebo-controlled. Trial. Drug. Res. (Stuttg), 2015, 65(11), 567-73.
[http://dx.doi.org/10.1055/s-0034-1389986] [PMID: 25268878]
[7]
Parsamanesh, N.; Moossavi, M.; Bahrami, A.; Butler, A.E.; Sahebkar, A. Therapeutic potential of curcumin in diabetic complications. Pharmacol Res., 2018, 136, 181-193.
[http://dx.doi.org/10.1016/j.phrs.2018.09.012] [PMID: 30219581]
[8]
Momtazi-Borojeni, A.A.; Haftcheshmeh, S.M.; Esmaeili, S.A.; Johnston, T.P.; Abdollahi, E.; Sahebkar, A. Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev., 2018, 17(2), 125-135.
[http://dx.doi.org/10.1016/j.autrev.2017.11.016] [PMID: 29180127] [http://dx.doi.org/10.1002/jcp.28122] [PMID: 30623450]
[9]
Sahebkar, A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil. Steril., 2010, 94(5), e75-e76.
[http://dx.doi.org/10.1016/j.fertnstert.2010.07.1071] [PMID: 20797714]
[10]
Heidari, Z.; Daei, M.; Boozari, M.; Jamialahmadi, T.; Sahebkar, A. Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytother. Res., 2022, 36(4), 1442-1458.
[http://dx.doi.org/10.1002/ptr.7350]
[11]
Mohammed, E.; El-Beih, N.; El-Hussieny, E.; El-Ahwany, E.; Hassan, M.; Zoheiry, M. Effects of free and nanoparticulate curcumin on chemically induced liver carcinoma in an animal model. Arch. Med. Sci., 2021, 17(1), 218-227.
[http://dx.doi.org/10.5114/aoms.2020.93739] [PMID: 33488874]
[12]
Panahi, Y.; Khalili, N.; Sahebi, E.; Namazi, S.; Reiner, Ž.; Majeed, M.; Sahebkar, A. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complement. Ther. Med., 2017, 33, 1-5.
[http://dx.doi.org/10.1016/j.ctim.2017.05.006] [PMID: 28735818]
[13]
Vahedian-Azimi, A.; Abbasifard, M.; Rahimi-Bashar, F.; Guest, P.C.; Majeed, M.; Mohammadi, A.; Banach, M.; Jamialahmadi, T.; Sahebkar, A. Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: A systematic review of clinical trials. Nutrients, 2022, 14(2), 256.
[http://dx.doi.org/10.3390/nu14020256] [PMID: 35057437]
[14]
Ganjali, S.; Blesso, C.N.; Banach, M.; Pirro, M.; Majeed, M.; Sahebkar, A. Effects of curcumin on HDL functionality. Pharmacol. Res., 2017, 119, 208-218.
[http://dx.doi.org/10.1016/j.phrs.2017.02.008] [PMID: 28192240]
[15]
Iranshahi, M.; Sahebkar, A.; Hosseini, S.T.; Takasaki, M.; Konoshima, T.; Tokuda, H. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine, 2010, 17(3-4), 269-273.
[http://dx.doi.org/10.1016/j.phymed.2009.05.020] [PMID: 19577457]
[16]
Lv, K.J.; Chen, T.C.; Wang, G.H.; Yao, Y.N.; Yao, H. Clinical safety and efficacy of curcumin use for oral lichen planus: A systematic review. J. Dermatolog. Treat., 2019, 30(6), 605-611.
[http://dx.doi.org/10.1080/09546634.2018.1543849] [PMID: 30388912]
[17]
Mata, I.R.; Mata, S.R.; Menezes, R.C.R.; Faccioli, L.S.; Bandeira, K.K.; Bosco, S.M.D. Benefits of turmeric supplementation for skin health in chronic diseases: A systematic review. Crit. Rev. Food Sci. Nutr., 2021, 61(20), 3421-3435.
[http://dx.doi.org/10.1080/10408398.2020.1798353] [PMID: 32713186]
[18]
White, C.M.; Chamberlin, K.; Eisenberg, E. Curcumin, a turmeric extract, for oral lichen planus: A systematic review. Oral Dis., 2019, 25(3), 720-725.
[http://dx.doi.org/10.1111/odi.13034] [PMID: 30614166]
[19]
Amirchaghmaghi, M.; Pakfetrat, A.; Delavarian, Z.; Ghalavani, H.; Ghazi, A. Evaluation of the efficacy of curcumin in the treatment of oral lichen planus: A randomized controlled trial. J. Clin. Diagn. Res., 2016, 10(5), ZC134-ZC137.
[http://dx.doi.org/10.7860/JCDR/2016/16338.7870] [PMID: 27437348]
[20]
Chainani-Wu, N.; Madden, E.; Lozada-Nur, F.; Silverman, S., Jr High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J. Am. Acad. Dermatol., 2012, 66(5), 752-760.
[http://dx.doi.org/10.1016/j.jaad.2011.04.022] [PMID: 21907450]
[21]
Kia, S.J.; Basirat, M.; Mortezaie, T.; Moosavi, M.S. Comparison of oral Nano-Curcumin with oral prednisolone on oral lichen planus: A randomized double-blinded clinical trial. BMC Complement. Med. Ther., 2020, 20, 328.
[http://dx.doi.org/10.1186/s12906-020-03128-7]
[22]
Nosratzehi, T.; Arbabi-Kalati, F.; Hamishehkar, H.; Bagheri, S. Comparison of the effects of curcumin mucoadhesive paste and local corticosteroid on the treatment of erosive oral lichen planus lesions. J. Natl. Med. Assoc., 2018, 110(1), 92-97.
[http://dx.doi.org/10.1016/j.jnma.2017.01.011] [PMID: 29510851]
[23]
thomas, A.; Varma, B.; Kurup, S.; Jose, R.; Chandy, M.L.; Kumar, S.P.; Aravind, M.S.; Ramadas, A.A. Evaluation of efficacy of 1% curcuminoids as local application in management of oral lichen planus - interventional study. J. Clin. Diagn. Res., 2017, 11(4), ZC89-ZC93.
[http://dx.doi.org/10.7860/JCDR/2017/20898.9715] [PMID: 28571271]
[24]
Zeng, L.; Yang, T.; Yang, K.; Yu, G.; Li, J.; Xiang, W.; Chen, H. Curcumin and Curcuma longa extract in the treatment of 10 types of autoimmune diseases: A systematic review and meta-analysis of 31 randomized controlled trials. Front. Immunol., 2022, 13, 896476.
[http://dx.doi.org/10.3389/fimmu.2022.896476] [PMID: 35979355]
[25]
Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J. Altern. Complement. Med., 2003, 9(1), 161-168.
[http://dx.doi.org/10.1089/107555303321223035] [PMID: 12676044]
[26]
Soleimani, V.; Sahebkar, A.; Hosseinzadeh, H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances:Review. Phytother. Res., 2018, 32(6), 985-995.
[http://dx.doi.org/10.1002/ptr.6054] [PMID: 29480523]
[27]
Dhillon, N.; Aggarwal, B.B.; Newman, R.A.; Wolff, R.A.; Kunnumakkara, A.B.; Abbruzzese, J.L.; Ng, C.S.; Badmaev, V.; Kurzrock, R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res., 2008, 14(14), 4491-4499.
[http://dx.doi.org/10.1158/1078-0432.CCR-08-0024] [PMID: 18628464]
[28]
Dai, W.; Wang, H.; Fang, J.; Zhu, Y.; Zhou, J.; Wang, X.; Zhou, Y.; Zhou, M. Curcumin provides neuroprotection in model of traumatic brain injury via the Nrf2-ARE signaling pathway. Brain Res. Bull., 2018, 140, 65-71.
[http://dx.doi.org/10.1016/j.brainresbull.2018.03.020] [PMID: 29626606]
[29]
Ungurianu, A.; Zanfirescu, A. Margină D. Regulation of gene expression through food-curcumin as a sirtuin activity modulator. Plants, 2022, 11(13), 1741.
[http://dx.doi.org/10.3390/plants11131741] [PMID: 35807694]
[30]
Pan, M.H.; Lin-Shiau, S.Y.; Lin, J.K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NFκB activation in macrophages. Biochem. Pharmacol., 2000, 60(11), 1665-1676.
[http://dx.doi.org/10.1016/S0006-2952(00)00489-5] [PMID: 11077049]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy